The Musculoskeletal Cost of Organ Repair
器官修复的肌肉骨骼成本
基本信息
- 批准号:10349585
- 负责人:
- 金额:$ 31.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAcuteAddressAdrenal Cortex HormonesAdrenergic AgentsAmino AcidsAttenuatedBiological AssayBloodBurn injuryCachexiaCatabolismCell physiologyChemicalsCommunicationDataDiseaseEatingEnergy MetabolismExcisionFatty acid glycerol estersFractureGene ExpressionGrowthHepaticHepatomegalyHepatosplenomegalyImpairmentInjuryIntakeInterleukin-6InterventionKnock-outLiteratureLiverMalignant NeoplasmsMediatingMediator of activation proteinMetabolicMetabolismModelingMolecularMorbidity - disease rateMusMuscleMuscular AtrophyMusculoskeletalNatural regenerationNutritionalOperative Surgical ProceduresOrganOrgan ModelOxidesPathologicPathway interactionsPatientsPharmacologyPhaseProcessProductionReactionRecoveryReportingRoleSignal TransductionSkeletal MuscleSkin repairSocietiesStarvationSurgical InjuriesTestingTherapeuticTimeTissuesTraumaTraumatic injuryWorkcostcytokinehealingimprovedinjury recoveryliver cell proliferationlong bonemortalitymuscle formnutritionorgan injuryorgan regenerationorgan repairrepairedresponsesevere burnssevere injuryskeletal muscle wastingskin regenerationsurgery outcometissue regenerationtissue repairwasting
项目摘要
Surviving critical injury or surgery requires an essential catabolic recovery period that typically extends from
days to weeks. This catabolism, defined as “the breakdown of existing molecules into smaller units that are either
oxidized to release energy or used in other anabolic reactions” (Royal Chemical Society), is systemic, activates
rapid loss of skeletal muscle during the period of organ repair and regeneration, and resolves with recovery.
Cuthbertson originally reported the rapid loss of muscle in long-bone fracture patients in 1930, first terming it
“ebb and flow”. This process has subsequently been termed “hypermetabolism” or “the adrenergic-corticoid
phase”. Work by Rhoads and others found that this catabolic response, rather than nutritional intake, drives
repair and regeneration of tissues following critical injury (including elective surgery). In contrast to starvation,
the post-injury catabolic response is proportional to the degree of injury, supports ongoing energy needs, and
supplies critical substrates (amino acids, fats) to repair, and regenerate injured organs and tissues. Serious
injuries including major trauma, liver resection, and burns can require catabolic responses over days to weeks to
fully recover. Although optimizing preoperative nutrition improves surgical outcomes, it does not prevent muscle
catabolism. Conversely, an impaired catabolic response is associated with increased morbidity and mortality.
Although current literature has focused on pathological persistence of the catabolic response and energy
expenditure following injury, particularly after burns, acute catabolism is essential to survive injury. To
date, little work has addressed how the recovery from critical injury induces the release of metabolic substrates
from muscle and other stores to meet the acute requirement for the repair and regeneration of damaged organs.
Our data indicate that injured organs are repaired at the expense of skeletal muscle mass. Furthermore, we found
that tissue repair activates the catabolism of muscle partly through a liver mechanism. Understanding how we
heal following injury, and the role of muscle crosstalk in this process will open new paradigms for therapies after
critical injury. We hypothesize that post-injury catabolism of muscle is: 1) the critical systemic response needed
to supply substrates for the repair of damaged organs, 2) universal after critical injury, including both
controlled (surgery) and traumatic injury, 3) molecularly similar to muscle wasting of cachexia in cancer and
other disorders, including in activation of atrogenes like MuRF1, 4) mediated by the injured organs through
reciprocal, feed-forward Interleukin-6 (IL-6)/JAK/STAT to YAP/TAZ signaling, and 5) amenable to
pharmacologic interventions. Here we will 1) Define mechanisms of organ crosstalk in liver growth
and muscle wasting; 2) Define mechanisms of organ crosstalk via the IL-6/YAP/TAZ pathway in
serious burn injury and investigate the therapeutic potential of YAP/TAZ modulation to augment
recovery from injury; 3) Interrogate the IL-6/YAP/TAZ pathway in blood and muscle from
patients with major liver resection or critical injury requiring delayed abdominal closure.
在重伤或手术中幸存下来需要一个基本的分解代谢恢复期,通常从
几天到几周。这种分解代谢的定义是“现有分子分解成更小的单位,这些单位或者
氧化以释放能量或用于其他合成代谢反应“(皇家化学会),是系统的,激活的
在器官修复和再生期间,骨骼肌迅速丧失,并随着恢复而消失。
Cuthbertson最初在1930年报道了长骨骨折患者肌肉的快速丧失,并首次将其命名为
“潮起潮落”。这一过程后来被称为“高代谢”或“肾上腺皮质激素”。
阶段“。Rhoads和其他人的研究发现,这种分解代谢反应,而不是营养摄入,推动了
严重损伤后组织的修复和再生(包括择期手术)。与饥饿相反的是,
损伤后的分解代谢反应与损伤程度成正比,支持持续的能量需求,以及
提供修复和再生受损器官和组织的关键底物(氨基酸、脂肪)。严重的
包括严重创伤、肝脏切除和烧伤在内的损伤可能需要几天到几周的分解代谢反应
完全康复。尽管优化手术前营养可以改善手术结果,但它并不能预防肌肉萎缩。
分解代谢。相反,分解代谢反应受损会增加发病率和死亡率。
虽然目前的文献关注的是分解代谢反应和能量的病理性持久性
受伤后的支出,尤其是烧伤后,急性分解代谢是受伤后存活的关键。至
到目前为止,很少有工作涉及危重损伤的恢复如何诱导代谢底物的释放。
从肌肉和其他存储,以满足修复和再生受损器官的迫切需求。
我们的数据表明,受损的器官是以骨骼肌质量为代价进行修复的。此外,我们发现,
这种组织修复在一定程度上通过肝脏机制激活肌肉的分解代谢。了解我们如何
受伤后愈合,肌肉串音在这一过程中的作用将为以后的治疗打开新的范式
伤势严重。我们假设肌肉损伤后的分解代谢是:1)所需的关键全身反应
为受损器官的修复提供底物,2)在严重损伤后普遍使用,包括两者
可控(手术)和创伤,3)分子上类似于癌症和癌症中恶病质的肌肉萎缩
其他障碍,包括由受损器官通过以下途径介导的诸如MuRF1,4)等萎缩基因的激活
与YAP/TAZ信号相互作用的前馈白介素6(IL-6)/JAK/STAT,以及5)服从
药物干预。在这里,我们将1)定义肝脏生长过程中器官串扰的机制
和肌肉萎缩;2)通过IL-6/YAP/TAZ途径确定器官串扰的机制
严重烧伤后YAP/TAZ调节增强治疗潜力的研究
3)检测血液和肌肉中IL-6/YAP/TAZ信号通路。
肝大部切除或严重损伤需延迟关腹的患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEONIDAS G. KONIARIS其他文献
LEONIDAS G. KONIARIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEONIDAS G. KONIARIS', 18)}}的其他基金
Core B – Human Biospecimen and Advanced Sequencing Core
核心 B — 人类生物样本和高级测序核心
- 批准号:
10634587 - 财政年份:2021
- 资助金额:
$ 31.19万 - 项目类别:
Core B – Human Biospecimen and Advanced Sequencing Core
核心 B — 人类生物样本和高级测序核心
- 批准号:
10172473 - 财政年份:2021
- 资助金额:
$ 31.19万 - 项目类别:
Core B – Human Biospecimen and Advanced Sequencing Core
核心 B — 人类生物样本和高级测序核心
- 批准号:
10441216 - 财政年份:2021
- 资助金额:
$ 31.19万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 31.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 31.19万 - 项目类别:
Operating Grants














{{item.name}}会员




